Protecting Your Pathology: Cybersecurity for Digital Workflows
Digital pathology opens up new cybersecurity risks for labs—but simple steps can mitigate those risks and increase digital resilience
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
Digital pathology opens up new cybersecurity risks for labs—but simple steps can mitigate those risks and increase digital resilience
On Jan. 11, the FDA warned consumers not to use COVID-19 tests from LuSys Laboratories, as they have not been approved for use in the US.